LidoFinance announced Turbulence Controls for its proposed decentralized lending market, Lido Lend, to guard against severe collateral disruptions such as hacks and liquidity problems. This follows the launch of a Guardian Security Council aimed at reviewing collateral and limiting exposure to risky assets and new attack methods. Lido Lend is based on a modified Morpho Blue design and plans to isolate markets for blue-chip assets and correlated pairs like stETH and Ether (ETH). These measures aim to enhance security and stability for lenders and borrowers in the platform.
LidoFinance's announcement of Turbulence Controls for Lido Lend provides context for readers following decentralized finance innovations. For readers following major cryptocurrencies on Pluang as of Oct 24, 2026 14:41 WIB, breadth showed 6 out of 50 major cryptocurrencies rising while 43 fell. Notable movers include SUSHI at Rp3.743 with a typical hold time of 102 days and a Pluang order activity of 21% Sell / 79% Buy, GRT at Rp420 with 28% Sell / 72% Buy, and LTC at Rp1.025.938 with 78% Sell / 22% Buy.
Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...
Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...
LlamaLend V2 strategy using 20x leverage on syrupUSDC reported a 37.1% yield, while another pool pairing sUSG with reUSD showed a 13.4% yield. The platform isolates lending markets with separate price feeds and borrowing caps, allowing supported Curv...
Solayer Pay has expanded its card app to accept stablecoin deposits directly from five blockchain networks: Solana, Ethereum, Arbitrum, BNB Chain, and Base. This update simplifies the process for users to fund their cards using stablecoins across mul...
Vertex Pharmaceuticals presented updates on its kidney disease research and development programs at the American Society of Nephrology (ASN) Kidney Week 2026. The event featured discussions on their portfolio, including new data on the AMKD program w...
